WHITNEY LIPSEY: Open Payments
NPI 1265897326 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 74 payments from 24 companies in 2025. Trend: 2023 $810 · 2024 $1,161 · 2025 $1,561
Food & beverage: $1,561
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $238 |
| Novo Nordisk Inc | 13 | $205 |
| Corcept Therapeutics | 7 | $180 |
| Abbott Laboratories | 6 | $114 |
| BETA BIONICS, INC. | 5 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $85 |
| Tandem Diabetes Care, Inc. | 3 | $78 |
| CeQur Corporation | 1 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Insulet Corporation | 2 | $46 |
Products named: Korlym, TEPEZZA, Ozempic, FREESTYLE LIBRE 3, iLet Bionic Pancreas, Wegovy, t:slim X2 Insulin Pump with Control-IQ, CeQur Simplicity.
Industry payments across GA — which companies pay providers there.
